Scarica l'app Stockscreener
15.99
0.19%
-0.008
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$16.00
Aprire:
$15.91
Volume 24 ore:
692.90K
Relative Volume:
0.23
Capitalizzazione di mercato:
$4.12B
Reddito:
$6.41B
Utile/perdita netta:
$1.30B
Rapporto P/E:
3.173
EPS:
5.04
Flusso di cassa netto:
$646.00M
1 W Prestazione:
+3.43%
1M Prestazione:
+5.62%
6M Prestazione:
-19.83%
1 anno Prestazione:
-7.16%
Intervallo 1D:
$15.75
$16.10
Intervallo di 1 settimana:
$15.24
$16.10
Portata 52W:
$13.87
$23.10
Organon Co Stock (OGN) Company Profile
Nome
Organon Co
Settore
Industria
Telefono
551-430-6000
Indirizzo
30 HUDSON STREET, JERSEY CITY
Confronta OGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
15.96 | 4.12B | 6.41B | 1.30B | 646.00M | 5.04 |
|
LLY
Lilly Eli Co
|
786.23 | 707.77B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
86.69 | 380.36B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
143.44 | 342.94B | 87.70B | 14.68B | 19.03B | 6.05 |
|
ABBV
Abbvie Inc
|
176.68 | 309.57B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
100.10 | 253.18B | 63.17B | 12.15B | 14.84B | 4.77 |
Organon Co Stock (OGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-06 | Downgrade | JP Morgan | Neutral → Underweight |
| 2023-11-03 | Downgrade | Goldman | Buy → Neutral |
| 2023-09-21 | Iniziato | Barclays | Overweight |
| 2023-03-16 | Iniziato | Raymond James | Outperform |
| 2022-10-14 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-09-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2021-10-07 | Iniziato | Piper Sandler | Neutral |
| 2021-09-01 | Iniziato | BofA Securities | Buy |
| 2021-07-22 | Iniziato | Citigroup | Buy |
| 2021-06-15 | Iniziato | JP Morgan | Neutral |
| 2021-06-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-06-10 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Organon Co Borsa (OGN) Ultime notizie
Douglas Lane & Associates LLC Sells 260,842 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon continues to partner with VNPA for National Population Action Month - vietnamnews.vn
Organon (OGN) Outpaces Stock Market Gains: What You Should Know - MSN
Range Financial Group LLC Purchases New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Long Term Investment Analysis - Stock Traders Daily
Organon & Co (OGN) Trading 3.21% Higher on Jan 4 - GuruFocus.com
Organon (OGN) Gains As Market Dips: What You Should Know - Yahoo Finance
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - MSN
Want $2,000 in Annual Dividends? Invest $11,000 in Each of These 3 Stocks. - The Motley Fool
Organon & Co (OGN) Shares Up 3.14% on Dec 31 - GuruFocus.com
Organon (OGN) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Principal Financial Group Inc. Decreases Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Shares Acquired by Barclays PLC - MarketBeat
Organon Korea sales and customers lead named new head for Organon Malaysia - KBR
Geode Capital Management LLC Acquires 82,220 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon To Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
Organon CEO to Present at J.P. Morgan Healthcare Conference in January 2025 - StockTitan
Organon's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Canada
Organon's SWOT analysis: stock poised for growth amid challenges - Investing.com
FDA approves Organon’s VTAMA cream, 1% for the treatment for AD - Yahoo Finance
Organon & Co. (NYSE:OGN) Stock Price Down 3.8%Here's Why - MarketBeat
Organon’s steroid-free cream Vtama wins approval in atopic dermatitis - Endpoints News
Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price - Simply Wall St
Te Ahumairangi Investment Management Ltd Reduces Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Organon's SWOT analysis: healthcare stock navigates growth amid challenges - Investing.com
125,654 Shares in Organon & Co. (NYSE:OGN) Purchased by Neo Ivy Capital Management - MarketBeat
Final Trades: Amazon, American Express and Organon - CNBC
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Fmr LLC Has $34.63 Million Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat
Systematic Financial Management LP Has $726,000 Stock Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. announces board member resignation - Investing.com
Organon & Co. announces board member resignation By Investing.com - Investing.com South Africa
Weiss Asset Management LP Acquires New Stake in Organon & Co. (NYSE:OGN) - MarketBeat
(OGN) Trading Report - Stock Traders Daily
Readystate Asset Management LP Has $4.65 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
Jacobs Levy Equity Management Inc. Grows Stake in Organon & Co. (NYSE:OGN) - MarketBeat
Edgestream Partners L.P. Buys New Position in Organon & Co. (NYSE:OGN) - MarketBeat
Bridgewater Associates LP Takes Position in Organon & Co. (NYSE:OGN) - MarketBeat
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Charles Schwab Investment Management Inc. Acquires 875,128 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Dynamic Technology Lab Private Ltd Invests $649,000 in Organon & Co. (NYSE:OGN) - MarketBeat
Organon Co Azioni (OGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):